SOPH
SOPH
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$99K
Insider Sales
99
$5.10M
Total Volume
$5.20M
100 transactions
Net Activity
$5.00M
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 98% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Camblong Jurgi
Exec COB
$2.71M total
Xu Zhenyu
Chief Scientific Officer
$786K total
Menu Philippe
Chief Medical Officer
$536K total
Verma Abhimanyu
CTO
$266K total
Muken Ross
CEO
$244K total
Quick Actions
SOPH has an insider buy conviction of 2%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at SOPH (SOPH) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 99 were sales. The total volume of insider trading reached $5.20M.
The net insider activity for SOPH shows a net selling bias of $5.00M. This activity represents a 2% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Camblong Jurgi (Exec COB), who traded 83.7K shares valued at $507K on Jun 29, 2026.
SOPH Stock Price and Chart — NASDAQ:SOPH
Understanding Momentum Shifts in (SOPH)
SOPH Stock Heads For Best Day In Over 8 Months – What’s Driving Today’s Super Rally?
SOPHiA GENETICS S.A. (SOPH) Stock Price History & Data
SOPH - SOPHiA Genetics SA Stock Price and Quote
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Up 6.2% - Should You Buy?
Related News & Analyst Reports
Read original insights and educational research covering SOPH and the Unknown sector.
FAQs About SOPH Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for SOPH.